Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $27.05 in the prior trading day, BridgeBio Pharma Inc (NASDAQ: BBIO) closed at $26.27, down -2.88%. In other words, the price has decreased by -$2.88 from its previous closing price. On the day, 0.82 million shares were traded. BBIO stock price reached its highest trading level at $27.11 during the session, while it also had its lowest trading level at $26.02.
Ratios:
Our goal is to gain a better understanding of BBIO by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.54 and its Current Ratio is at 5.54.
On January 31, 2024, BMO Capital Markets started tracking the stock assigning a Market Perform rating and target price of $37.
On December 08, 2023, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $58.Wells Fargo initiated its Overweight rating on December 08, 2023, with a $58 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 04 ’24 when Scott Randal W. sold 1,500 shares for $31.30 per share. The transaction valued at 46,950 led to the insider holds 4,000 shares of the business.
Scott Randal W. sold 1,000 shares of BBIO for $28,843 on Jun 03 ’24. The Director now owns 5,500 shares after completing the transaction at $28.84 per share. On Mar 01 ’24, another insider, Scott Randal W., who serves as the Director of the company, sold 2,500 shares for $34.00 each. As a result, the insider received 85,000 and left with 6,500 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BBIO now has a Market Capitalization of 4915878912 and an Enterprise Value of 6137637888. For the stock, the TTM Price-to-Sale (P/S) ratio is 22.49. Its current Enterprise Value per Revenue stands at 28.077 whereas that against EBITDA is -13.158.
Stock Price History:
Over the past 52 weeks, BBIO has reached a high of $44.32, while it has fallen to a 52-week low of $21.62. The 50-Day Moving Average of the stock is -3.47%, while the 200-Day Moving Average is calculated to be -13.06%.
Shares Statistics:
The stock has traded on average 1.92M shares per day over the past 3-months and 1292810 shares per day over the last 10 days, according to various share statistics. A total of 175.08M shares are outstanding, with a floating share count of 140.78M. Insiders hold about 24.77% of the company’s shares, while institutions hold 73.50% stake in the company. Shares short for BBIO as of 1721001600 were 21049935 with a Short Ratio of 10.97, compared to 1718323200 on 16661668. Therefore, it implies a Short% of Shares Outstanding of 21049935 and a Short% of Float of 17.36.
